東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Acute myeloid leukemia in children =...

Tomizawa, Daisuke.

FindBook

Google Book

Amazon

博客來

Acute myeloid leukemia in children = standard of care and future perspectives /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Acute myeloid leukemia in children/ edited by Daisuke Tomizawa, Edward Anders Kolb, Dirk Reinhardt.
其他題名:	standard of care and future perspectives /
其他作者:	Tomizawa, Daisuke.
出版者:	Cham :Springer Nature Switzerland : : 2024.,
面頁冊數:	viii, 342 p. :ill. (chiefly col.), digital ;24 cm.
內容註:	Part-1: Epidemiology and Biology of Pediatric AML. Overview and Epidemiology of Pediatric AML -- Chromosomal and Genomic Alterations in Pediatric AML -- Germline Predisposition of Pediatric AML. Part-2: Diagnosis of pediatric AML. Diagnosis and Classifications of Pediatric AML -- Measurable Residual Disease Assessment in Pediatric AML. Part-3: Advances in Treatment of Pediatric AML. De Novo AML -- Extramedullary AML (CNS disease. non-CNS extramedullary disease. and myeloid sarcoma) -- Acute Promyelocytic Leukemia -- Myeloid Proliferations Associated with Down Syndrome (ML-DS. TAM) -- Myeloproliferative Disorders in Non-Down Syndrome Patients -- AML in Specific Age Groups (Infants. Adolescents and Young Adults) -- Myeloid Neoplasms Post Cytotoxic Therapy in Children -- Advanced MDS in Children -- Relapsed/Refractory AML in Children and Evolution of Novel Therapies -- Stem Cell Transplantation/Cellular and Immunotherapies -- Pediatric AML in Resource-Limited Countries. Part-4: Supportive Issues in Pediatric AML. Infection Management in Pediatric AML -- Cardiotoxicity in Pediatric AML -- Late effects in Pediatric AML Survivors.
Contained By:	Springer Nature eBook
標題:	Acute myeloid leukemia in children. -
電子資源:	https://doi.org/10.1007/978-3-031-63366-9
ISBN:	9783031633669

Acute myeloid leukemia in children = standard of care and future perspectives /
Acute myeloid leukemia in childrenstandard of care and future perspectives /[electronic resource] :edited by Daisuke Tomizawa, Edward Anders Kolb, Dirk Reinhardt. - Cham :Springer Nature Switzerland :2024. - viii, 342 p. :ill. (chiefly col.), digital ;24 cm. - Pediatric oncology,2191-0812. - Pediatric oncology..

Part-1: Epidemiology and Biology of Pediatric AML. Overview and Epidemiology of Pediatric AML -- Chromosomal and Genomic Alterations in Pediatric AML -- Germline Predisposition of Pediatric AML. Part-2: Diagnosis of pediatric AML. Diagnosis and Classifications of Pediatric AML -- Measurable Residual Disease Assessment in Pediatric AML. Part-3: Advances in Treatment of Pediatric AML. De Novo AML -- Extramedullary AML (CNS disease. non-CNS extramedullary disease. and myeloid sarcoma) -- Acute Promyelocytic Leukemia -- Myeloid Proliferations Associated with Down Syndrome (ML-DS. TAM) -- Myeloproliferative Disorders in Non-Down Syndrome Patients -- AML in Specific Age Groups (Infants. Adolescents and Young Adults) -- Myeloid Neoplasms Post Cytotoxic Therapy in Children -- Advanced MDS in Children -- Relapsed/Refractory AML in Children and Evolution of Novel Therapies -- Stem Cell Transplantation/Cellular and Immunotherapies -- Pediatric AML in Resource-Limited Countries. Part-4: Supportive Issues in Pediatric AML. Infection Management in Pediatric AML -- Cardiotoxicity in Pediatric AML -- Late effects in Pediatric AML Survivors.

This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.

ISBN: 9783031633669

Standard No.: 10.1007/978-3-031-63366-9doiSubjects--Topical Terms:

3753613
Acute myeloid leukemia in children.

LC Class. No.: RJ416.A25

Dewey Class. No.: 618.9299419

Acute myeloid leukemia in children = standard of care and future perspectives /
LDR:03146nmm a22003495a 4500 001 2388501
003 DE-He213
005 20240820130305.0
006 m d
007 cr nn 008maaau
008 250916s2024 sz s 0 eng d
020 $a 9783031633669 $q (electronic bk.)
020 $a 9783031633652 $q (paper)
024 7 $a 10.1007/978-3-031-63366-9 $2 doi
035 $a 978-3-031-63366-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RJ416.A25
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 618.9299419 $2 23
090 $a RJ416.A25 $b A189 2024
245 0 0 $a Acute myeloid leukemia in children $h [electronic resource] : $b standard of care and future perspectives / $c edited by Daisuke Tomizawa, Edward Anders Kolb, Dirk Reinhardt.
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a viii, 342 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
347 $a text file $b PDF $2 rda
490 1 $a Pediatric oncology, $x 2191-0812
505 0 $a Part-1: Epidemiology and Biology of Pediatric AML. Overview and Epidemiology of Pediatric AML -- Chromosomal and Genomic Alterations in Pediatric AML -- Germline Predisposition of Pediatric AML. Part-2: Diagnosis of pediatric AML. Diagnosis and Classifications of Pediatric AML -- Measurable Residual Disease Assessment in Pediatric AML. Part-3: Advances in Treatment of Pediatric AML. De Novo AML -- Extramedullary AML (CNS disease. non-CNS extramedullary disease. and myeloid sarcoma) -- Acute Promyelocytic Leukemia -- Myeloid Proliferations Associated with Down Syndrome (ML-DS. TAM) -- Myeloproliferative Disorders in Non-Down Syndrome Patients -- AML in Specific Age Groups (Infants. Adolescents and Young Adults) -- Myeloid Neoplasms Post Cytotoxic Therapy in Children -- Advanced MDS in Children -- Relapsed/Refractory AML in Children and Evolution of Novel Therapies -- Stem Cell Transplantation/Cellular and Immunotherapies -- Pediatric AML in Resource-Limited Countries. Part-4: Supportive Issues in Pediatric AML. Infection Management in Pediatric AML -- Cardiotoxicity in Pediatric AML -- Late effects in Pediatric AML Survivors.
520 $a This book provides up-to-date information on key topics and issues in Pediatric Acute Myeloid Leukemia (AML), including the epidemiology, biology, diagnosis and treatment of particular forms of the disease, supportive care, and survivorship. The entire spectrum of clinical management on pediatric AML is covered with the aim of equipping readers with the latest knowledge relevant to clinical practice and research, based on enormous efforts made by cooperative clinical trial groups and consortia worldwide. Each chapter is written by internationally renowned authorities who have been selected for their expertise in the subjects discussed. This book will serve pediatric hematologists/oncologists, fellows, and residents both as a comprehensive source of information and as a quick reference. The book will also be of interest to pediatricians and general practitioners.
650 0 $a Acute myeloid leukemia in children. $3 3753613
650 1 4 $a Hematology. $3 808260
650 2 4 $a Oncology. $3 751006
650 2 4 $a Pediatrics. $3 559143
700 1 $a Tomizawa, Daisuke. $3 3753610
700 1 $a Kolb, Edward Anders. $3 3753611
700 1 $a Reinhardt, Dirk. $3 3753612
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
830 0 $a Pediatric oncology. $3 1568090
856 4 0 $u https://doi.org/10.1007/978-3-031-63366-9
950 $a Medicine (SpringerNature-11650)